Developer docs
API playgroundTry for free, no card

Search company profiles

Twill

Full company profile

uuid0000f9k

Namestring
Twill
Legal namestring
Twill Inc.
Websiteurl
twill.health
Company typeenum
Private
Founded yearint
2012
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
digital therapeutics, behavioral health platform, mental health solutions, chronic condition management, patient engagement platform
Industry2 codes
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Offices of Physicians, Mental Health Specialists621112
SIC code1 code
  • Services-Health Services8000
Product category
Digital Therapeutics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1B2B Enterprise Licensing
TypeSubscription Recurring
Description

Platform licensing to enterprise clients including health plans, employers, and pharmaceutical companies. Twill partners with these organizations to improve outcomes and deliver measurable value through a unified care platform configured to client needs.

twill.health
2Pharma Partnerships
TypeSubscription Recurring
Description

Revenue from pharmaceutical companies for digital patient engagement solutions, including condition-specific Sequences, therapeutic programs, and patient support solutions. Twill has worked with over 12 pharmaceutical companies including 10 of the top 20.

blog.twill.health
3D2C Apps
TypeSubscription Recurring
Description

Direct-to-consumer applications including Twill Care, Twill Therapeutics, and Happify Health providing digital well-being and therapeutic interventions to individual consumers.

twill.health
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Marketing or Sales, Operations
Pricing details2 tiers
1Proof of Concept (POC) Pilot
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Entry-level POC pilots typically cost between $250-500K with deployment in 2-4 months depending on requirements. Available for various therapeutic areas including migraine, MS, atopic dermatitis, asthma, rheumatoid arthritis, diabetes, hypertension, breast cancer, lung cancer, pregnancy, major depressive disorder, and generalized anxiety disorder.

blog.twill.health
2Enterprise Scale Deployment
ModelSubscriptionBilling cadenceAnnual
Notes

Scaling digital solutions beyond POC typically requires under $1-2M per year with adjustments, refinement, and additional features based on patient feedback.

blog.twill.health
GTM typeB2B and B2C
B2B and B2C
Offering typeSoftware
Software
Brand1 of 4 records shown
1Twill Care
Description

Patient-centric community support platform for chronic conditions considering both mind and body

twill.health
+3 more records
Core offering1 text field

Twill operates a clinical-grade digital therapeutics platform (Intelligent Healing Platform) that combines AI-powered personalization, evidence-based behavioral interventions, and configurable care journeys (Sequences) for mental health, maternal health, and chronic condition management. The platform integrates prescription and non-prescription digital therapeutics, clinically-moderated peer communities, coaching, and third-party services into unified care experiences. It is sold to enterprise clients (health plans, employers, pharmaceutical companies) and to individual consumers through mobile apps.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 26% anxiety reduction, 27% well-being increase for psoriasis users completing 16+ activities
+5 more records
Product overview1 text field

Twill operates as The Intelligent Healing Company, offering a unified digital health platform that combines multiple products and modules. The core portfolio includes Twill Care (community support for chronic conditions), Twill Therapeutics/Dario Mind (digital therapeutics), and Happify by Twill (well-being app), all orchestrated through the Sequences configuration system and the overarching Intelligent Healing Platform. Following Dario's acquisition of Twill in early 2024, these capabilities are being integrated into Dario's multi-condition platform, which also includes Dario Connect for community-based support across conditions like pregnancy, MS, psoriasis, and women's midlife health. The platform leverages Therapeutic Intelligence AI to personalize care journeys and delivers evidence-based interventions across mental health, maternal health, and chronic condition management, touching more than 18 million lives globally in 10 languages.

Product and service1 record
1Twill Care (now Dario Connect)
Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership6 partners
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-10-01
Description

DarioHealth acquired Twill in October 2024, combining two digital health companies to create the most comprehensive consumer-centric digital health platform. The combined entity provides best-in-class support for mental well-being, maternal health, and chronic conditions including diabetes, hypertension, weight management, and musculoskeletal pain. The merger created immediate scale with four of the top five health plans, multiple Fortune 100 employers, and major pharmaceutical companies as customers.

2The Lattice Initiative
Strategic tierMinorTypeStrategic or Co-development Partner
Description

The Lattice Initiative is a non-profit organization dedicated to defining best practices in the mental health area, and promoting their broader use in the behavioral world, with the goal of improving outcomes and access to quality and accountable care. An unaffiliated partner of Twill.

twill.health
3National Psoriasis Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Twill Care for Psoriasis became the official online community for the National Psoriasis Foundation in 2021. Over 65,000 people with psoriasis can access Twill's digital healthcare community, bringing together healthcare professionals with high-quality digital tools and peer support.

blog.twill.health
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to support Multiple Sclerosis patients through digital engagement solutions. Twill developed MS Sequences to help patients manage their condition.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Almirall partnered with Twill to go live with a digital solution supporting psoriasis patients. Twill provides the platform and digital therapeutics while Almirall provides pharmaceutical expertise and branding.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership to enhance maternal health for Medicaid members with a digital-first solution. Twill provides perinatal programs across the pregnancy journey, including mental health support and health literacy content for Elevance Medicaid members.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor combining a consumer mental-wellness app with an enterprise B2B platform (Headspace for Work, Headspace for Healthcare, Headspace for Education) sold to employers, health plans, and clinicians. Highly comparable to Twill's Happify by Twill + Sequences positioning.

2Calm
TypeDirect peer
Description

Leading consumer mental wellness and meditation app with a growing Calm Health and Calm Business enterprise offering targeting payers, employers, and providers. Overlaps directly with Twill's mindfulness/CBT-based content and employer mental-health benefits motion.

TypeDirect peer
Description

Mental health benefits platform sold to employers and health plans, blending self-guided digital content with live therapy and coaching. Direct comparison to Twill's blended DTx + coached care journey model for Fortune 100 employers.

TypeDirect peer
Description

Employer-focused mental health platform offering digital self-care, coaching, therapy, and psychiatric services. Competes for the same payer/employer RFPs as Twill's mental-health Sequences.

TypeOthers
TypeDirect peer
Description

Digital therapeutics company selling Sleepio (insomnia) and Daylight (anxiety) to health plans, employers, and providers. Comparable as a clinical-grade DTx player targeting the same payer/employer procurement channels with evidence-based outcomes.

TypeDirect peer
Description

Virtual care company combining digital tools with human coaching for diabetes prevention, diabetes, hypertension, and musculoskeletal conditions, sold to payers and employers. Overlaps with Twill's chronic-condition Sequences and Sequences-style configuration approach.

TypeDirect peer
Description

Prescription and consumer digital therapeutic company with FDA-cleared products for ADHD and cognitive dysfunction. Comparable as a regulated DTx peer with payer-facing commercialization, though smaller scale.

TypeBroad incumbent
Description

Large incumbent virtual care company offering telehealth, mental health (BetterHelp), and chronic condition management (Livongo) to payers, employers, and consumers. Provides broad competitive pressure across Twill's full portfolio, but does not specialize in Twill's clinical-grade DTx niche.

TypeEmerging player
Description

AI-chatbot-delivered digital therapeutic for mental health, working with payers, employers, and pharma. Comparable AI-driven behavioral intervention approach to Twill's Taylor chatbot, though narrower in therapeutic scope and condition coverage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles13 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds10 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Twill

Digital Therapeuticstwill.health

Twill firmographics

Firmographics
Name
Twill
Legal name
Twill Inc.
Website
https://twill.health
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Twill industry classification

Industry
Product category
Digital Therapeutics
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112)
SIC
Services-Health Services (8000)
akta.pro industry
PRIMARYHLACANAI
Behavioral Health & Neurocognitive Therapeutics (Digital)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLACANAJ
Digital Rehabilitation & Physical Therapy Therapeutics
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Digital therapeutics
  • Behavioral health platform
  • Mental health solutions
  • Chronic condition management
  • Patient engagement platform

Where Twill is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Twill business model

Business model
GTM type
B2B and B2C
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

  1. B2B Enterprise Licensing: Platform licensing to enterprise clients including health plans, employers, and pharmaceutical companies. Twill partners with these organizations to improve outcomes and deliver measurable value through a unified care platform configured to client needs.
  2. Pharma Partnerships: Revenue from pharmaceutical companies for digital patient engagement solutions, including condition-specific Sequences, therapeutic programs, and patient support solutions. Twill has worked with over 12 pharmaceutical companies including 10 of the top 20.
  3. D2C Apps: Direct-to-consumer applications including Twill Care, Twill Therapeutics, and Happify Health providing digital well-being and therapeutic interventions to individual consumers.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractProof of Concept (POC) Pilot
SubscriptionAnnualEnterprise Scale Deployment

Go-to-market motion1 record

Distribution channels4 records

Marketing channels10 records

Twill product offering

Product offering

Core offering

Twill operates a clinical-grade digital therapeutics platform (Intelligent Healing Platform) that combines AI-powered personalization, evidence-based behavioral interventions, and configurable care journeys (Sequences) for mental health, maternal health, and chronic condition management. The platform integrates prescription and non-prescription digital therapeutics, clinically-moderated peer communities, coaching, and third-party services into unified care experiences. It is sold to enterprise clients (health plans, employers, pharmaceutical companies) and to individual consumers through mobile apps.

Product overview

Twill operates as The Intelligent Healing Company, offering a unified digital health platform that combines multiple products and modules. The core portfolio includes Twill Care (community support for chronic conditions), Twill Therapeutics/Dario Mind (digital therapeutics), and Happify by Twill (well-being app), all orchestrated through the Sequences configuration system and the overarching Intelligent Healing Platform. Following Dario's acquisition of Twill in early 2024, these capabilities are being integrated into Dario's multi-condition platform, which also includes Dario Connect for community-based support across conditions like pregnancy, MS, psoriasis, and women's midlife health. The platform leverages Therapeutic Intelligence AI to personalize care journeys and delivers evidence-based interventions across mental health, maternal health, and chronic condition management, touching more than 18 million lives globally in 10 languages.

Differentiator

Problem solved

Functional benefit

Brands

  • Twill Care: Patient-centric community support platform for chronic conditions considering both mind and body
  • Twill Therapeutics
  • Happify by Twill
  • Sequences

Products and services

  • Twill Care (now Dario Connect)

Quantifiable outcome

  • 26% anxiety reduction, 27% well-being increase for psoriasis users completing 16+ activities
  • +5 more outcomes

Companies that use Twill

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Twill technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Twill partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered flagship, minor and core.

  • DarioHealthflagshipStrategic or Co-development Partner · 1 October 2024DarioHealth acquired Twill in October 2024, combining two digital health companies to create the most comprehensive consumer-centric digital health platform. The combined entity provides best-in-class support for mental well-being, maternal health, and chronic conditions including diabetes, hypertension, weight management, and musculoskeletal pain. The merger created immediate scale with four of the top five health plans, multiple Fortune 100 employers, and major pharmaceutical companies as customers.
  • The Lattice InitiativeminorStrategic or Co-development PartnerThe Lattice Initiative is a non-profit organization dedicated to defining best practices in the mental health area, and promoting their broader use in the behavioral world, with the goal of improving outcomes and access to quality and accountable care. An unaffiliated partner of Twill.
  • National Psoriasis FoundationcoreStrategic or Co-development PartnerTwill Care for Psoriasis became the official online community for the National Psoriasis Foundation in 2021. Over 65,000 people with psoriasis can access Twill's digital healthcare community, bringing together healthcare professionals with high-quality digital tools and peer support.
  • BiogencoreStrategic or Co-development PartnerPartnership to support Multiple Sclerosis patients through digital engagement solutions. Twill developed MS Sequences to help patients manage their condition.
  • AlmirallcoreStrategic or Co-development PartnerAlmirall partnered with Twill to go live with a digital solution supporting psoriasis patients. Twill provides the platform and digital therapeutics while Almirall provides pharmaceutical expertise and branding.
  • Elevance Health (formerly Anthem)coreStrategic or Co-development PartnerPartnership to enhance maternal health for Medicaid members with a digital-first solution. Twill provides perinatal programs across the pregnancy journey, including mental health support and health literacy content for Elevance Medicaid members.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Twill competitors and assessment

Company assessment

Direct peers

  • Headspace Health: Direct competitor combining a consumer mental-wellness app with an enterprise B2B platform (Headspace for Work, Headspace for Healthcare, Headspace for Education) sold to employers, health plans, and clinicians. Highly comparable to Twill's Happify by Twill + Sequences positioning.
  • Calm: Leading consumer mental wellness and meditation app with a growing Calm Health and Calm Business enterprise offering targeting payers, employers, and providers. Overlaps directly with Twill's mindfulness/CBT-based content and employer mental-health benefits motion.
  • Lyra Health: Mental health benefits platform sold to employers and health plans, blending self-guided digital content with live therapy and coaching. Direct comparison to Twill's blended DTx + coached care journey model for Fortune 100 employers.
  • Modern Health: Employer-focused mental health platform offering digital self-care, coaching, therapy, and psychiatric services. Competes for the same payer/employer RFPs as Twill's mental-health Sequences.
  • Big Health: Digital therapeutics company selling Sleepio (insomnia) and Daylight (anxiety) to health plans, employers, and providers. Comparable as a clinical-grade DTx player targeting the same payer/employer procurement channels with evidence-based outcomes.
  • Omada Health: Virtual care company combining digital tools with human coaching for diabetes prevention, diabetes, hypertension, and musculoskeletal conditions, sold to payers and employers. Overlaps with Twill's chronic-condition Sequences and Sequences-style configuration approach.
  • Akili Interactive: Prescription and consumer digital therapeutic company with FDA-cleared products for ADHD and cognitive dysfunction. Comparable as a regulated DTx peer with payer-facing commercialization, though smaller scale.

Others

Broad incumbents

  • Teladoc Health (BetterHelp, Livongo): Large incumbent virtual care company offering telehealth, mental health (BetterHelp), and chronic condition management (Livongo) to payers, employers, and consumers. Provides broad competitive pressure across Twill's full portfolio, but does not specialize in Twill's clinical-grade DTx niche.

Emerging players

  • Woebot Health: AI-chatbot-delivered digital therapeutic for mental health, working with payers, employers, and pharma. Comparable AI-driven behavioral intervention approach to Twill's Taylor chatbot, though narrower in therapeutic scope and condition coverage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

Twill social profiles

Digital presence

Twill compliance and trust

Trust signal

Compliance3 records

Twill financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Twill leadership team

Management profile

Number of profiles

Profiles13 records

Twill subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Twill funding detail

Funding detail

Funding overview

Funding rounds10 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Twill M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Twill

What does Twill do?

Twill operates a clinical-grade digital therapeutics platform (Intelligent Healing Platform) that combines AI-powered personalization, evidence-based behavioral interventions, and configurable care journeys (Sequences) for mental health, maternal health, and chronic condition management. The platform integrates prescription and non-prescription digital therapeutics, clinically-moderated peer communities, coaching, and third-party services into unified care experiences. It is sold to enterprise clients (health plans, employers, pharmaceutical companies) and to individual consumers through mobile apps.

Is Twill a public or private company?

Twill is a private company. It is classified as corporate owned and is currently operating.

When was Twill founded?

Twill was founded in 2012. It employs 51 to 100 people.

Where is Twill based?

Twill is headquartered in New York, United States, in the North America region.

How does Twill make money?

Three revenue lines are on record. B2B Enterprise Licensing is the primary driver. The others are pharma Partnerships and D2C Apps.

Who are Twill's main competitors?

Direct peers on record are Headspace Health, Calm, Lyra Health, Modern Health, Big Health, Omada Health and Akili Interactive. Spring Health is listed as an others. Teladoc Health (BetterHelp, Livongo) is listed as a broad incumbent. Woebot Health is listed as an emerging player.

Does Twill have an API?

No public API is recorded for Twill.

What industry is Twill in?

Twill's product category is Digital Therapeutics. Its primary akta.pro industry code is HLACANAI, Behavioral Health & Neurocognitive Therapeutics (Digital), with a secondary code of HLACANAJ, Digital Rehabilitation & Physical Therapy Therapeutics. Its NAICS code is 621420 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
IwinsMore Employers Offering Wellness, Mental Health ChatbotsA survey by Willis Towers Watson found that 24% of 457 U.S. employers currently offer digital therapeutic apps for mental health support, with another 15% considering adding such offerings in 2024 or 2025. Companies like Amazon are offering therapist-like apps such as Twill, while products like Wysa and Woebot have received FDA breakthrough designation or target specific conditions like postpartum depression. The article notes ongoing controversy, including an $8 million FTC settlement with BetterHelp over data sharing and concerns that these apps are not equipped to handle serious mental health issues.Pharmashots20 Innovative Digital Therapeutics Companies of 2025PharmaShots published a feature ranking the 20 most innovative digital therapeutics companies of 2025, profiling each company's founding year, headquarters, key products, and recent developments. Notable highlights include Omada Health's June 2025 IPO on Nasdaq raising $150M at a $1.28B valuation, SWORD Health's $130M Series D funding round valuing the company at $3B, and Click Therapeutics' $145M Series C round. The feature also captures significant mergers, acquisitions, and partnerships across the sector, including Headspace Health's merger with Ginger to form a $3B digital mental health company and DarioHealth's acquisition of Twill to expand its behavioral health capabilities.PR NewswireDarioHealth Reports First Quarter 2024 Financial and Operating ResultsDarioHealth reported first-quarter 2024 revenue of $5.8 million, driven by a 176% year-over-year increase in its core B2B2C channel and the consolidation of revenues from its recent acquisition of Twill Inc. The company anticipates reaching a breakeven run rate in the second half of 2025, supported by expected cost synergies that should reduce operating expenses by 30% by the end of the year.PR NewswireDarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating ResultsDarioHealth Corp. reported fourth quarter 2023 revenue of $3.6 million, a 47% decline from Q4 2022, and full-year 2023 revenue of $20.4 million, down 26.4% year-over-year, due to a managed decrease in B2C and strategic milestone revenue. The company's core B2B2C business grew 39% year-over-year, and gross profit for full-year 2023 was $6.0 million versus $9.7 million in 2022. Concurrent with the earnings release, Dario announced the completed acquisition of Twill, Inc. in Q1 2024, accompanied by a $22.4 million equity financing, which the company expects to create a combined entity with approximately $38 million in pro forma revenues.Pulse 2.0Dario To Buy Digital-Led Care Company TwillDarioHealth acquired Twill, a digital-led care company, to expand its chronic condition offerings. The deal is expected to nearly double pro forma 2023 revenue and reach 80-85% gross margins by 2025, with cost synergies of nearly 30% within two years. Twill's CEO will join Dario's leadership team as COO.STATDarioHealth acquires Twill, hoping it’s a shortcut to profitabilityDarioHealth acquired digital mental health company Twill for $10 million in cash plus stock valued over $20 million. The move aims to attract large customers, but DarioHealth remains unprofitable, having lost over $40 million in the first nine months of 2023.DariohealthDario and Twill Join Forces to Shape Digital Health's FutureDario and Twill have joined forces to create a unified digital health platform, combining their respective expertise in chronic condition management and mental/maternal health support. The transaction creates immediate scale with customers including four of the top five health plans and major Fortune 100 employers, aiming to deliver integrated care solutions.MassDeviceDarioHealth acquires digital health company Twill, prices $22.4M offeringDarioHealth acquired digital health company Twill for $10 million in cash plus approximately 10 million shares, while simultaneously pricing a $22.4 million private placement of convertible preferred stock. The transaction is expected to nearly double DarioHealth's pro forma 2023 revenue and provide immediate cost synergies through the integration of Twill's wellbeing and navigation solutions.ForbesEmotion AI: Why It's The Future Of Digital HealthEmotion AI, which helps machines understand human emotions, is being applied in digital health for diagnostics and caregiver support. LUCID uses it to curate personalized music for dementia patients, while Twill's chatbot provides empathetic mental health support. Concerns about bias and responsible AI development are also addressed.Business Wire BlogTwill Deepens Telebehavioral Health Offering with e-Psychiatry PartnershipTwill partnered with e-Psychiatry to add access to psychiatrists, psychologists, and therapists for higher acuity patients. The collaboration integrates e-Psychiatry's telebehavioral services into Twill's Sequences platform, expanding its Precision Care offerings. The partnership aims to increase access to mental health professionals and improve patient engagement.